Express Scripts Holding Company (NASDAQ:ESRX) has been given an average rating of “Hold” by the twenty-five research firms that are presently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $69.67.

ESRX has been the subject of a number of research analyst reports. ValuEngine upgraded Express Scripts Holding from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Jefferies Group LLC set a $72.00 price target on Express Scripts Holding and gave the company a “buy” rating in a research report on Tuesday, August 29th. Zacks Investment Research upgraded Express Scripts Holding from a “hold” rating to a “buy” rating and set a $64.00 price target for the company in a research report on Monday, October 16th. Mizuho set a $67.00 price target on Express Scripts Holding and gave the company a “hold” rating in a research report on Tuesday, October 24th. Finally, Needham & Company LLC initiated coverage on Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating for the company.

ILLEGAL ACTIVITY WARNING: “Express Scripts Holding Company (ESRX) Receives $69.67 Consensus Target Price from Analysts” was first published by Daily Political and is the property of of Daily Political. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.dailypolitical.com/2017/11/11/express-scripts-holding-company-esrx-receives-69-67-consensus-target-price-from-analysts.html.

In related news, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total transaction of $71,501.24. Following the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Phyllis S. Anderson sold 578 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the transaction, the vice president now directly owns 10,530 shares in the company, valued at $664,758.90. The disclosure for this sale can be found here. Insiders sold a total of 6,284 shares of company stock worth $397,421 over the last ninety days. Corporate insiders own 0.68% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Express Scripts Holding by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock worth $2,652,964,000 after acquiring an additional 649,400 shares in the last quarter. Dodge & Cox lifted its position in Express Scripts Holding by 25.7% during the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after acquiring an additional 7,388,021 shares in the last quarter. State Street Corp lifted its position in Express Scripts Holding by 1.1% during the 1st quarter. State Street Corp now owns 27,060,709 shares of the company’s stock worth $1,783,569,000 after acquiring an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its position in Express Scripts Holding by 4.2% during the 1st quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock worth $1,160,862,000 after acquiring an additional 704,218 shares in the last quarter. Finally, Macquarie Group Ltd. lifted its position in Express Scripts Holding by 8.4% during the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock worth $758,480,000 after acquiring an additional 922,406 shares in the last quarter. 90.30% of the stock is currently owned by hedge funds and other institutional investors.

Express Scripts Holding (NASDAQ:ESRX) traded down $0.70 during trading on Monday, reaching $60.05. The company’s stock had a trading volume of 3,608,400 shares, compared to its average volume of 4,115,587. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $77.50. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $34,407.16, a P/E ratio of 8.88, a P/E/G ratio of 0.90 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting analysts’ consensus estimates of $1.90. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. The company had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter last year, the company earned $1.74 earnings per share. Express Scripts Holding’s quarterly revenue was down 2.9% compared to the same quarter last year. equities analysts anticipate that Express Scripts Holding will post 7.01 EPS for the current fiscal year.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.